raghenieb's profile picture. Content strateeg. Culinaire columns @pshetparool. Eerste kookboek apr ‘24 @nijgh

Raghenie Bhawanie

@raghenieb

Content strateeg. Culinaire columns @pshetparool. Eerste kookboek apr ‘24 @nijgh

I’m a fan. #treatyoself

Meet Aloe Bud. The app uses friendly-looking pixel-art icons and gentle reminders and log bits of self-care: meals eaten, glasses of water drank, medications taken. In the time of Covid-19 and social distancing, more and more people are turning to it. wired.trib.al/pdp8nt5



Repost di Raghenie Bhawanie

Congratulations to our RWD lead @TBPolak for having his paper being published  - “Expanded Access as a source of Real-world data: An overview of FDA and EMA approvals”- Download the paper - bit.ly/3cn6KBB & learn more - bit.ly/3ag4Ykr  - #RWD #ExpandedAccess

myTomorrows's tweet image. Congratulations to our RWD lead @TBPolak for having his paper being published  - “Expanded Access as a source of Real-world data: An overview of FDA and EMA approvals”- Download the paper -  bit.ly/3cn6KBB & learn more - bit.ly/3ag4Ykr  - #RWD #ExpandedAccess
myTomorrows's tweet image. Congratulations to our RWD lead @TBPolak for having his paper being published  - “Expanded Access as a source of Real-world data: An overview of FDA and EMA approvals”- Download the paper -  bit.ly/3cn6KBB & learn more - bit.ly/3ag4Ykr  - #RWD #ExpandedAccess
myTomorrows's tweet image. Congratulations to our RWD lead @TBPolak for having his paper being published  - “Expanded Access as a source of Real-world data: An overview of FDA and EMA approvals”- Download the paper -  bit.ly/3cn6KBB & learn more - bit.ly/3ag4Ykr  - #RWD #ExpandedAccess
myTomorrows's tweet image. Congratulations to our RWD lead @TBPolak for having his paper being published  - “Expanded Access as a source of Real-world data: An overview of FDA and EMA approvals”- Download the paper -  bit.ly/3cn6KBB & learn more - bit.ly/3ag4Ykr  - #RWD #ExpandedAccess

Repost di Raghenie Bhawanie

Here’s @Zolley, our AI Research Director, giving a lecture at the AI & Society Course at the @tudelft. He’s highlighting the importance of not only using AI for society but using AI the right way. (1/2) - #AI #EthicalAI #EthicalAIDesign

myTomorrows's tweet image. Here’s @Zolley, our AI Research Director, giving a lecture at the AI & Society Course at the @tudelft. He’s highlighting the importance of not only using AI for society but using AI the right way. (1/2) - #AI #EthicalAI #EthicalAIDesign

Repost di Raghenie Bhawanie

There are more than 300 million people living with a #RareDisease worldwide. @myTomorrows supports rare disease patients around the globe in their search for all possible treatment options. #RareDiseaseDay


"My dad taught us 'you are as good as anybody in this town, but you're no better.' I don't have a feeling of inferiority. Never had. I'm as good as anybody, but no better." <3 #KatherineJohnson nasa.gov/centers/langle…


Repost di Raghenie Bhawanie

A story from @MaastrichtU about how our CTO @rsips combines fries, anatomy lessons and artificial intelligence - bit.ly/32r1usT #AI #MachineLearning #HealthTech

myTomorrows's tweet image. A story from @MaastrichtU about how our CTO @rsips combines fries, anatomy lessons and artificial intelligence - bit.ly/32r1usT #AI #MachineLearning #HealthTech

Repost di Raghenie Bhawanie

Today's the day. Introducing our new partnership with @mptherapeutics! Together we are making information and treatment options more accessible for oncologists and their patients all over the world - bit.ly/37DFxb6 - #colorectalcancer #bowelcancer #CRCSM

myTomorrows's tweet image. Today&apos;s the day. Introducing our new partnership with @mptherapeutics! 
Together we are making information and treatment options more accessible for oncologists and their patients all over the world - bit.ly/37DFxb6 - #colorectalcancer #bowelcancer #CRCSM

Repost di Raghenie Bhawanie

T2. When an organization improves access to information or to care, that provides real value to patients. Here’s a prime example: @myTomorrows is helping patients learn about all their possible treatment options and get help accessing them. #hcldr

Time for T2: Which parts of healthcare consumerism provide value for patients? Can the drive to emulate an "Amazon-like" marketplace create barriers to patient access and positive outcomes? #hcldr @JoeBabaian

hcldr's tweet image. Time for T2: Which parts of healthcare consumerism provide value for patients? Can the drive to emulate an &quot;Amazon-like&quot; marketplace create barriers to patient access and positive outcomes?

#hcldr @JoeBabaian


Repost di Raghenie Bhawanie

We are extremely pleased to announce our new collaboration with AiCuris to initiate an Early Access Program for Pritelivir - bit.ly/2tQE0k5 - #Expandedaccess #HSV #Herpes #Pritelivir - @AiCuris

myTomorrows's tweet image. We are extremely pleased to announce our new collaboration with AiCuris to initiate an Early Access Program for Pritelivir - bit.ly/2tQE0k5 - #Expandedaccess #HSV #Herpes #Pritelivir - @AiCuris

Repost di Raghenie Bhawanie

A dutch language blogpost has been published today, in collaboration with @awscloud, on the work @myTomorrows and @EEMCS_TUD are doing to make medical information accessible to patients. sprout.nl/persberichten/…


Repost di Raghenie Bhawanie

There is low patient enrollment in clinical trials. Patients need more education and access to this process. Providers are also key to helping match patients with clinical trials that could potentially save their life. This should not be left to luck.


Repost di Raghenie Bhawanie

@myTomorrows offer a brilliant free service tracking down trials for you. My oncologist was very impressed with the options they found for me.


Repost di Raghenie Bhawanie

Great to have Eline Bunnik present “Ethical issues in Expanded Access” at our HQ - bit.ly/36VdNjh - @ErasmusMC #expandedaccess #bioethics

myTomorrows's tweet image. Great to have Eline Bunnik present “Ethical issues in Expanded Access” at our HQ - bit.ly/36VdNjh - @ErasmusMC #expandedaccess #bioethics

Repost di Raghenie Bhawanie

Phd student @sepidehmesbah87 presenting today at #emnlp2019 Nice joint work between @wisdelft (@ChristophLofi, @gjhouben, @mvallet91), @yangjiera from Amazon, and @myTomorrows (@rsips )

Adverse Drug reaction in user generated content. Problem of handling layman language (informal medical terms), lack of training data, various strategies #emnlp2019

MKrallinger's tweet image. Adverse Drug reaction in user generated content. Problem of handling layman language (informal medical terms), lack of training data, various strategies  #emnlp2019
MKrallinger's tweet image. Adverse Drug reaction in user generated content. Problem of handling layman language (informal medical terms), lack of training data, various strategies  #emnlp2019
MKrallinger's tweet image. Adverse Drug reaction in user generated content. Problem of handling layman language (informal medical terms), lack of training data, various strategies  #emnlp2019
MKrallinger's tweet image. Adverse Drug reaction in user generated content. Problem of handling layman language (informal medical terms), lack of training data, various strategies  #emnlp2019


👏🏽 Colin Kaepernick's Nike ad wins Emmy for outstanding commercial - CNN cnn.com/2019/09/15/ent…


Repost di Raghenie Bhawanie

I am a happy user, so yes, please, let @christianreber have @wunderlist back.

Still sad @Microsoft wants to shut down @Wunderlist, even though people still love and use it. I’m serious @satyanadella @marcusash, please let me buy it back. Keep the team and focus on @MicrosoftToDo, and no one will be angry for not shutting down @Wunderlist.

christianreber's tweet image. Still sad @Microsoft wants to shut down @Wunderlist, even though people still love and use it. I’m serious @satyanadella @marcusash, please let me buy it back. Keep the team and focus on @MicrosoftToDo, and no one will be angry for not shutting down @Wunderlist.


United States Tendenze

Loading...

Something went wrong.


Something went wrong.